Skip to main content
. 2020 Nov 27;12(4):1433–1444. doi: 10.1039/d0sc06195f

Fig. 5. Schematic representation of the active site in the E-I complex and details of the H-bond interactions between the inhibitor and the active site of the SARS-CoV-2 Mpro from QM/MM MD simulations of compound B1 (a) and compound B2 (b).

Fig. 5